June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Biomarkers to monitor progression in MERTK retinopathy
Author Affiliations & Notes
  • Elisa Eleanor Cornish
    Faculty of Medicine and Health, The University of Sydney, Save Sight Institute, Sydney, New South Wales, Australia
  • Nina Mustafic
    Faculty of Medicine and Health, The University of Sydney, Save Sight Institute, Sydney, New South Wales, Australia
  • Dhimas Hari Sakti
    Faculty of Medicine and Health, The University of Sydney, Save Sight Institute, Sydney, New South Wales, Australia
    Department of Ophthalmology, Faculty of Medicine, Public Health, and Nursing; Universitas Gadjah Mada, Yogyakarta, Yogyakarta, Indonesia
  • Afsah Zaheer
    Faculty of Medicine and Health, The University of Sydney, Save Sight Institute, Sydney, New South Wales, Australia
  • Stephanie Retsas
    Faculty of Medicine and Health, The University of Sydney, Save Sight Institute, Sydney, New South Wales, Australia
  • Robyn V Jamieson
    The University of Sydney, Children's Medical Research Institute, Sydney, New South Wales, Australia
  • John R Grigg
    Faculty of Medicine and Health, The University of Sydney, Save Sight Institute, Sydney, New South Wales, Australia
  • Footnotes
    Commercial Relationships   Elisa Cornish, None; Nina Mustafic, None; Dhimas Hari Sakti, None; Afsah Zaheer, None; Stephanie Retsas, None; Robyn Jamieson, NHMRC (F); John Grigg, NHRMC (F), NOVARTIS (C)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 1906. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Elisa Eleanor Cornish, Nina Mustafic, Dhimas Hari Sakti, Afsah Zaheer, Stephanie Retsas, Robyn V Jamieson, John R Grigg; Biomarkers to monitor progression in MERTK retinopathy. Invest. Ophthalmol. Vis. Sci. 2020;61(7):1906.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : MERTK, a tyrosine kinase receptor protein expressed by the retinal pigment epithelium (RPE), is mutated in a rare group of autosomal retinitis pigmentosa (RP) patients. The purpose of this study is to investigate biomarkers in MERTK-RP patients.

Methods : Medical records for MERTK genetically confirmed patients attending the Save Sight Institute 2014 - 2019 were reviewed. Best corrected visual acuity (BCVA) and spectral domain optical coherence tomography (SD-OCT) central macular thickness (CMT) and ellipsoid zone (EZ) length were assessed. Ultra-widefield fundus autofluorescence (UW-FAF) identified patterns of change by qualitative grading (Hypo-AF/Hyper-AF areas). Semi-automated kinetic perimetry (SKP) used III4e and V4e stimuli. ISCEV standard full field electroretinogram (ffERG) and pattern electroretinogram (pERG) were analysed.

Results : Ten eyes from 5 subjects (2 siblings) mean age 25.2 yrs (19-45.9). Mean follow-up 51.7 months (24.6-66.9). BCVA mean at presentation 0.88 ± 0.83 range 0.30 to 2.40 logMar. Mean BCVA at last visit 1.10 ±0.87. Mean reduction in acuity was 0.22 LogMar equivalent to 0.05 logMar units per year. This rate of loss will lead to BCVA progressing to legal blindness for all eyes in approximately 14 years. All patients had a myopic refraction. Mean CMT at presentation 184.7µ ± 32.9, mean last visit CMT 152.6µ±17, mean reduction in CMT 32.1±21µ with a rate of -7.45 µ per year. OCT showed shortening of the EZ then disruption into discrete hyperreflective bodies which migrated to the outer nuclear layer. EZ could be measured in 8 eyes at initial visit (mean 1297±416µ) and 7 eyes at last visit (mean 784±285µ). ffERG confirmed a rod-cone dystrophy. PERG was identifiable in only one patient. AF showed several different phenotypes, but each had a central macular speckled hyperAF correlating with macular atrophy, a diffuse mid peripheral hyperAF in addition 2 had a hypoAF areas corresponding to the retinal vascular arcades. SKP (III4e and V4e) was normal in 2 eyes, restricted nasal field in four eyes, superior wedge defect in 2 eyes and undetectable in 2 eyes.

Conclusions : In this young cohort visual loss (BCVA) occurred early due to macular dysfunction with CMT and EZ line decline. Visual field assessment (SKP) showed relative peripheral field preservation. This study identifies the relatively rapid decline in BCVA in MERTK -RP patients providing guidance to timing for intervention with therapeutic clinical trials.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×